药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
19-Nor-4-androstenedione
Encorafenib
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Encorafenib.
19-Nor-4-androstenedione
Ivosidenib
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Ivosidenib.
19-Nor-4-androstenedione
Dexverapamil
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Dexverapamil.
19-Nor-4-androstenedione
Penfluridol
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Penfluridol.
19-Nor-4-androstenedione
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Dexchlorpheniramine.
19-Nor-4-androstenedione
Lorcainide
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Lorcainide.
19-Nor-4-androstenedione
Bunaftine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Bunaftine.
19-Nor-4-androstenedione
Nizofenone
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Nizofenone.
19-Nor-4-androstenedione
Otilonium
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Otilonium.
19-Nor-4-androstenedione
Sultopride
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Sultopride.
19-Nor-4-androstenedione
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Sitafloxacin.
19-Nor-4-androstenedione
Oxatomide
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Oxatomide.
19-Nor-4-androstenedione
Abexinostat
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Abexinostat.
19-Nor-4-androstenedione
Mizolastine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Mizolastine.
19-Nor-4-androstenedione
Ricolinostat
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Ricolinostat.
19-Nor-4-androstenedione
Simendan
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Simendan.
19-Nor-4-androstenedione
CUDC-101
The risk or severity of QTc prolongation can be increased when Bilastine is combined with CUDC-101.
19-Nor-4-androstenedione
Gilteritinib
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Gilteritinib.
19-Nor-4-androstenedione
Entinostat
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Entinostat.
19-Nor-4-androstenedione
Mocetinostat
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Mocetinostat.